Anna Vassall

Anna Vassall

  • Senior Fellow
  • Joep Lange Chair Holder
  • Professor of Health Economics
  • LSHTM

Anna Vassall is a health economist with over thirty years of experience in economic analysis and research in low- and middle- income countries. A key interest of hers is in methods to incorporate health systems and other constraints and a societal/equity focused perspective into economic evaluation and priority setting. She has extensive experience supporting national health planning and priority setting, aid effectiveness, and cost-effectiveness analysis in a wide range of low- and middle- income countries. She is currently the Director of the Global Health Economics Centre in London (GHECO) and sits in the Department of Global Health at LSHTM. She is a founding member of the TB-MAC modelling consortium and sits on the technical advisory group for health technology assessment at WHO, as well as currently supporting several countries develop health benefit packages as part of the Disease Control Priorities (DCP) and International Decision Support Initiative projects.

Previously she has led a wide range of influential economic analyses on HIV prevention for key populations (Avahan programme), the integration and organisation of HIV care and treatment services (Integra project), and new diagnostics for TB (Xpert MTB/RIF) and the prevention of violence against women and girls (What Works). She has also sat on the Strategic and Technical Advisory Group for the WHO’s Global TB Programme (STAG-TB) and Task Force on Catastrophic Cost Measurement for TB, and on the Lancet Commission for TB.

View Anna’s publications (PubMed)